Psyence
0
Press Release Oct 31: Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
0

PsyLabs develops and produces certified pharmaceutical-grade nature-derived psychedelics for applications in mental health and ...

0
Psyence Biomed adds Australian site for psilocybin trial
0

Press Release NEW YORK – Psyence Biomedical Ltd. (NASDAQ:PBM), a biotechnology company specializing in nature-derived psychedelic ...

0
Press Release: Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
0

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company ...

0
Your Cart is empty!

It looks like you haven't added any items to your cart yet.

Browse Products
Powered by Caddy